Status: Recruiting
Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes
This Phase 2a clinical trial is a dose escalation study of the safety, tolerability, and efficacy of hepatocyte transplantation into lymph nodes via endoscopic ultrasound among subjects with end-stage liver disease.
Participants needed: 12
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: LyGenesis, Inc.Updated: Aug 8, 2025Locations: 2
Eligibility criteria
Have read, understood, and signed the informed consent form (ICF). [+11]
Has primary hepatic neoplasms (hepatocellular carcinoma and cholangiocarcinoma). [+13]